The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice

Belik, DM; Bernasconi, R; Xu, LF; Della Verde, G; Lorenz, V; Grüterich, V; Balzarolo, M; Mochizuki, M; Pfister, O; Kuster, GM

Kuster, GM (通讯作者),Univ Hosp Basel, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.;Kuster, GM (通讯作者),Univ Basel, Hebelstr 20, CH-4031 Basel, Switzerland.;Kuster, GM (通讯作者),Univ Hosp Basel, Univ Heart Ctr, Dept Cardiol, Basel, Switzerland.

APOPTOSIS, 2023; ():

Abstract

BackgroundTyrosine kinase inhibitors (TKIs) targeting fms-like tyrosine kinase 3 (Flt3) such as quizartinib were specifically designed for acute myelo......

Full Text Link